Initial experience with SPECT examinations using [123I]IBZM as a D2-dopamine receptor antagonist in Parkinson's disease (Q48733775)
Jump to navigation
Jump to search
scientific article published on May 1, 1991
Language | Label | Description | Also known as |
---|---|---|---|
English | Initial experience with SPECT examinations using [123I]IBZM as a D2-dopamine receptor antagonist in Parkinson's disease |
scientific article published on May 1, 1991 |
Statements
1 reference
Initial experience with SPECT examinations using [123I]IBZM as a D2-dopamine receptor antagonist in Parkinson's disease (English)
1 reference
M. Cordes
H. Henkes
D. Laudahn
H. Bräu
W. Kramp
W. Girke
J. Hierholzer
H. Eichstädt
1 May 1991
1 reference
1 reference
12
1 reference
3
1 reference
182-186
1 reference
1 reference
1 reference
1 reference
1 reference